| # | Drug | Count |
|---|---|---|
| 0 | ENALAPRIL | 7 |
| 1 | SIMVASTATIN | 7 |
| 2 | AMLODIPINE | 6 |
| 3 | ENALAPRIL MALEATE | 6 |
| 4 | METHOTREXATE SODIUM | 5 |
| 5 | PREDNISOLONE | 5 |
| 6 | PREDNISOLONE ORAL | 5 |
| 7 | PREDNISOLONE ORAL SOLUTION | 5 |
| 8 | ASFOTASE ALFA | 4 |
| 9 | ETANERCEPT | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ASFOTASE ALFA | 4 | 0.0004 |
| 1 | MINOCYCLINE | 4 | 0.0003 |
| 2 | MINOCYCLINE HYDROCHLORIDE | 2 | 0.0003 |
| 3 | ENALAPRIL MALEATE | 6 | 0.0002 |
| 4 | CYCLOSPORINE OPHTHALMIC SOLUTION | 1 | 0.0002 |
| 5 | CLOFAZIMINE | 1 | 0.0002 |
| 6 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 7 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 8 | OFLOXACIN OTIC | 1 | 0.0001 |
| 9 | OFLOXACIN | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 4 | 0.0004 |
| 1 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 2 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 3 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 4 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 5 | Insulin [EPC] | 1 | 0.0000 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 7 | 0.0000 |
| 7 | Dihydropyridine Calcium Channel Blocker [EPC] | 6 | 0.0000 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Anti-IgE [EPC] | 1 | 0.0000 |